| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.671 | 0.004 | 0.671 | 5 Hydroxytryptamine 7 antagonist | 0.506 0.004 DBMET01842 0.562 0.004 DBMET01843 0.542 0.004 DBMET01844 | ||
| 0.659 | 0.008 | 0.659 | Spasmolytic | 0.466 0.028 DBMET01842 0.566 0.016 DBMET01843 0.462 0.029 DBMET01844 | ||
| 0.639 | 0.003 | 0.639 | 5 Hydroxytryptamine 1F antagonist | 0.531 0.004 DBMET01842 0.554 0.004 DBMET01843 0.562 0.004 DBMET01844 | ||
| 0.618 | 0.004 | 0.618 | 5 Hydroxytryptamine 2B antagonist | 0.516 0.005 DBMET01842 0.452 0.006 DBMET01843 0.315 0.014 DBMET01844 | ||
| 0.605 | 0.005 | 0.605 | 5 Hydroxytryptamine antagonist | 0.511 0.007 DBMET01842 0.386 0.012 DBMET01843 0.278 0.021 DBMET01844 | ||
| 0.596 | 0.004 | 0.679 | Antihistaminic | 0.572 0.004 DBMET01842 0.426 0.005 DBMET01843 0.679 0.004 DBMET01844 | DBMET01844 | |
| 0.568 | 0.003 | 0.568 | 5 Hydroxytryptamine 1E antagonist | 0.333 0.014 DBMET01842 0.442 0.004 DBMET01843 0.386 0.005 DBMET01844 | ||
| 0.567 | 0.004 | 0.62 | Histamine antagonist | 0.55 0.004 DBMET01842 0.399 0.006 DBMET01843 0.62 0.004 DBMET01844 | DBMET01844 | |
| 0.563 | 0.005 | 0.563 | 5 Hydroxytryptamine 2 antagonist | 0.463 0.007 DBMET01842 0.4 0.01 DBMET01843 0.256 0.021 DBMET01844 | ||
| 0.553 | 0.004 | 0.553 | Alpha 2b adrenoreceptor antagonist | 0.534 0.004 DBMET01842 0.336 0.007 DBMET01843 0.282 0.011 DBMET01844 | ||
| 0.544 | 0.004 | 0.544 | Nav1.3 sodium channel blocker | 0.223 0.018 DBMET01842 0.421 0.004 DBMET01843 0.283 0.01 DBMET01844 | ||
| 0.526 | 0.004 | 0.526 | 5 Hydroxytryptamine 2C antagonist | 0.293 0.009 DBMET01842 0.452 0.005 DBMET01843 0.203 0.017 DBMET01844 | ||
| 0.489 | 0.004 | 0.489 | Alpha 2c adrenoreceptor antagonist | 0.396 0.004 DBMET01842 0.259 0.009 DBMET01843 0.224 0.013 DBMET01844 | ||
| 0.475 | 0.005 | 0.475 | Dopamine D2 antagonist | 0.216 0.015 DBMET01842 0.214 0.015 DBMET01843 0.464 0.005 DBMET01844 | ||
| 0.475 | 0.006 | 0.475 | Dopamine antagonist | 0.203 0.018 DBMET01842 0.241 0.015 DBMET01843 0.425 0.007 DBMET01844 | ||
| 0.447 | 0.005 | 0.447 | 5 Hydroxytryptamine 2A antagonist | 0.31 0.011 DBMET01842 0.239 0.016 DBMET01843 0.164 0.025 DBMET01844 | ||
| 0.498 | 0.061 | 0.498 | Caspase 9 stimulant | 0.476 0.07 DBMET01843 | ||
| 0.423 | 0.005 | 0.439 | Acetylcholine M1 receptor antagonist | 0.439 0.005 DBMET01842 0.322 0.011 DBMET01843 0.293 0.016 DBMET01844 | DBMET01842 | |
| 0.422 | 0.009 | 0.422 | Alpha adrenoreceptor antagonist | 0.323 0.014 DBMET01842 0.337 0.013 DBMET01843 0.137 0.041 DBMET01844 | ||
| 0.409 | 0.005 | 0.504 | Alpha 2a adrenoreceptor antagonist | 0.256 0.009 DBMET01842 0.504 0.004 DBMET01843 0.162 0.02 DBMET01844 | DBMET01843 | |
| 0.406 | 0.005 | 0.406 | Alpha 1b adrenoreceptor antagonist | 0.283 0.008 DBMET01842 0.197 0.015 DBMET01843 0.172 0.018 DBMET01844 | ||
| 0.401 | 0.003 | 0.401 | Acetylcholine M4 receptor antagonist | 0.276 0.004 DBMET01842 0.302 0.004 DBMET01843 0.211 0.005 DBMET01844 | ||
| 0.402 | 0.005 | 0.402 | Alpha 2 adrenoreceptor antagonist | 0.246 0.012 DBMET01842 0.387 0.005 DBMET01843 0.162 0.024 DBMET01844 | ||
| 0.364 | 0.005 | 0.364 | Nav1.6 sodium channel blocker | 0.194 0.021 DBMET01842 0.214 0.015 DBMET01843 0.185 0.026 DBMET01844 | ||
| 0.354 | 0.005 | 0.528 | Histamine H1 receptor antagonist | 0.528 0.004 DBMET01842 0.131 0.029 DBMET01843 0.436 0.004 DBMET01844 | DBMET01842 | |
| 0.356 | 0.01 | 0.356 | Nav1.2 sodium channel blocker | 0.139 0.064 DBMET01842 0.309 0.014 DBMET01843 0.145 0.06 DBMET01844 | ||
| 0.351 | 0.005 | 0.351 | Nav1.1 sodium channel blocker | 0.234 0.014 DBMET01842 0.27 0.01 DBMET01843 0.255 0.011 DBMET01844 | ||
| 0.419 | 0.076 | 0.495 | Analgesic | 0.495 0.051 DBMET01842 0.352 0.107 DBMET01843 | DBMET01842 | |
| 0.337 | 0.01 | 0.337 | Anesthetic local | 0.17 0.041 DBMET01842 0.241 0.022 DBMET01843 0.136 0.056 DBMET01844 | ||
| 0.329 | 0.004 | 0.329 | 5 Hydroxytryptamine 1B antagonist | 0.111 0.019 DBMET01842 0.181 0.01 DBMET01843 0.115 0.018 DBMET01844 | ||
| 0.324 | 0.005 | 0.324 | Dopamine D1 antagonist | 0.324 0.005 DBMET01842 0.158 0.014 DBMET01843 0.11 0.022 DBMET01844 | ||
| 0.33 | 0.012 | 0.33 | Cholinergic antagonist | 0.275 0.017 DBMET01842 0.242 0.023 DBMET01843 0.194 0.034 DBMET01844 | ||
| 0.315 | 0.013 | 0.315 | Acetylcholine antagonist | 0.263 0.018 DBMET01842 0.232 0.024 DBMET01843 0.188 0.034 DBMET01844 | ||
| 0.335 | 0.041 | 0.447 | HERG channel blocker | 0.447 0.021 DBMET01842 0.232 0.074 DBMET01843 0.269 0.059 DBMET01844 | DBMET01842 | |
| 0.296 | 0.004 | 0.296 | Sphingomyelinase inhibitor | 0.16 0.02 DBMET01842 0.264 0.004 DBMET01843 0.178 0.015 DBMET01844 | ||
| 0.303 | 0.011 | 0.303 | Alpha 1 adrenoreceptor antagonist | 0.227 0.017 DBMET01842 0.16 0.028 DBMET01843 0.094 0.046 DBMET01844 | ||
| 0.297 | 0.01 | 0.303 | Calcium channel blocker | 0.294 0.01 DBMET01842 0.303 0.009 DBMET01843 0.277 0.013 DBMET01844 | DBMET01843 | |
| 0.27 | 0.003 | 0.27 | 5 Hydroxytryptamine 6 antagonist | 0.204 0.004 DBMET01842 0.21 0.004 DBMET01843 0.184 0.004 DBMET01844 | ||
| 0.277 | 0.016 | 0.277 | NADPH oxidase inhibitor | 0.209 0.032 DBMET01843 | ||
| 0.311 | 0.052 | 0.423 | Cardiotonic | 0.423 0.025 DBMET01842 0.218 0.104 DBMET01843 0.322 0.048 DBMET01844 | DBMET01842 | |
| 0.303 | 0.043 | 0.322 | 5 Hydroxytryptamine uptake stimulant | 0.322 0.035 DBMET01843 0.252 0.079 DBMET01844 | DBMET01843 | |
| 0.3 | 0.049 | 0.392 | Potassium channel (Voltage-sensitive) blocker | 0.392 0.028 DBMET01842 0.218 0.084 DBMET01843 0.237 0.073 DBMET01844 | DBMET01842 | |
| 0.263 | 0.013 | 0.263 | Acetylcholine muscarinic antagonist | 0.241 0.016 DBMET01842 0.186 0.028 DBMET01843 0.178 0.031 DBMET01844 | ||
| 0.349 | 0.1 | 0.423 | Histamine release inhibitor | 0.423 0.064 DBMET01842 0.314 0.116 DBMET01843 | DBMET01842 | |
| 0.259 | 0.013 | 0.272 | 5 Hydroxytryptamine 3E antagonist | 0.182 0.1 DBMET01842 0.272 0.009 DBMET01843 0.242 0.02 DBMET01844 | DBMET01843 | |
| 0.242 | 0.004 | 0.242 | Acetylcholine M5 receptor antagonist | 0.148 0.008 DBMET01842 0.17 0.006 DBMET01843 0.125 0.011 DBMET01844 | ||
| 0.257 | 0.029 | 0.257 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.128 0.078 DBMET01842 0.256 0.029 DBMET01843 0.103 0.1 DBMET01844 | ||
| 0.23 | 0.005 | 0.23 | Dopamine uptake inhibitor | 0.223 0.005 DBMET01842 0.184 0.007 DBMET01843 0.133 0.012 DBMET01844 | ||
| 0.238 | 0.014 | 0.238 | 5 Hydroxytryptamine 1 antagonist | 0.161 0.021 DBMET01842 0.113 0.032 DBMET01843 0.065 0.058 DBMET01844 | ||
| 0.232 | 0.01 | 0.232 | Acetylcholine nicotinic antagonist | 0.152 0.02 DBMET01842 0.192 0.013 DBMET01843 0.096 0.042 DBMET01844 | ||
| 0.214 | 0.006 | 0.214 | 5 Hydroxytryptamine 1D antagonist | 0.2 0.007 DBMET01842 0.12 0.017 DBMET01843 0.113 0.019 DBMET01844 | ||
| 0.224 | 0.02 | 0.224 | Antiadrenergic | 0.175 0.029 DBMET01842 0.21 0.023 DBMET01843 0.101 0.055 DBMET01844 | ||
| 0.294 | 0.093 | 0.396 | Vasodilator, coronary | 0.303 0.085 DBMET01842 0.396 0.036 DBMET01843 | DBMET01843 | |
| 0.257 | 0.056 | 0.257 | Psychostimulant | 0.167 0.102 DBMET01843 0.224 0.069 DBMET01844 | ||
| 0.218 | 0.02 | 0.218 | Adrenaline antagonist | 0.17 0.03 DBMET01842 0.205 0.023 DBMET01843 0.097 0.055 DBMET01844 | ||
| 0.2 | 0.005 | 0.2 | Histamine H2 receptor antagonist | 0.164 0.008 DBMET01842 0.133 0.015 DBMET01843 0.13 0.016 DBMET01844 | ||
| 0.256 | 0.064 | 0.461 | Potassium channel blocker | 0.461 0.014 DBMET01842 0.279 0.054 DBMET01844 | DBMET01842 | |
| 0.196 | 0.007 | 0.196 | Acetylcholine M2 receptor antagonist | 0.114 0.018 DBMET01842 0.116 0.017 DBMET01843 0.128 0.015 DBMET01844 | ||
| 0.198 | 0.011 | 0.198 | Dopamine D3 antagonist | 0.159 0.014 DBMET01842 0.081 0.032 DBMET01843 0.081 0.032 DBMET01844 | ||
| 0.202 | 0.016 | 0.202 | Alpha 1a adrenoreceptor antagonist | 0.075 0.048 DBMET01842 0.079 0.046 DBMET01843 | ||
| 0.289 | 0.121 | 0.298 | Calpain 2 inhibitor | 0.298 0.115 DBMET01843 | DBMET01843 | |
| 0.229 | 0.066 | 0.245 | Anticonvulsant | 0.206 0.078 DBMET01842 0.245 0.059 DBMET01844 | DBMET01844 | |
| 0.176 | 0.013 | 0.176 | 5 Hydroxytryptamine uptake inhibitor | 0.074 0.036 DBMET01842 0.162 0.014 DBMET01843 0.102 0.025 DBMET01844 | ||
| 0.176 | 0.015 | 0.211 | Nitric-oxide synthase inhibitor | 0.18 0.014 DBMET01842 0.211 0.008 DBMET01843 0.102 0.057 DBMET01844 | DBMET01843 | |
| 0.215 | 0.06 | 0.348 | Non-steroidal antiinflammatory agent | 0.348 0.02 DBMET01842 0.14 0.131 DBMET01843 0.159 0.105 DBMET01844 | DBMET01842 | |
| 0.176 | 0.023 | 0.209 | Calcium channel (voltage-sensitive) blocker | 0.209 0.015 DBMET01842 0.144 0.037 DBMET01843 0.138 0.041 DBMET01844 | DBMET01842 | |
| 0.156 | 0.006 | 0.156 | Dopamine D5 antagonist | 0.078 0.013 DBMET01842 0.065 0.017 DBMET01843 0.072 0.014 DBMET01844 | ||
| 0.176 | 0.026 | 0.176 | Butyrylcholinesterase inhibitor | 0.119 0.047 DBMET01842 0.106 0.057 DBMET01843 | ||
| 0.165 | 0.022 | 0.165 | Heat shock protein 70 antagonist | 0.15 0.045 DBMET01843 0.134 0.101 DBMET01844 | ||
| 0.146 | 0.008 | 0.146 | 5 Hydroxytryptamine 5A antagonist | 0.134 0.009 DBMET01843 0.069 0.033 DBMET01844 | ||
| 0.156 | 0.024 | 0.156 | Nav1.5 sodium channel blocker | 0.104 0.077 DBMET01843 0.106 0.075 DBMET01844 | ||
| 0.147 | 0.015 | 0.147 | Alpha 1d adrenoreceptor antagonist | 0.11 0.021 DBMET01842 0.072 0.034 DBMET01843 | ||
| 0.226 | 0.095 | 0.24 | Tyrosine 3 hydroxylase inhibitor | 0.193 0.149 DBMET01842 0.24 0.078 DBMET01843 0.193 0.149 DBMET01844 | DBMET01843 | |
| 0.143 | 0.011 | 0.143 | Calcium channel L-type blocker | 0.124 0.015 DBMET01842 0.136 0.012 DBMET01843 0.099 0.025 DBMET01844 | ||
| 0.202 | 0.073 | 0.202 | Anesthetic general | |||
| 0.139 | 0.012 | 0.139 | Alpha 2d adrenoreceptor antagonist | 0.129 0.018 DBMET01842 0.124 0.021 DBMET01843 0.126 0.019 DBMET01844 | ||
| 0.151 | 0.026 | 0.151 | Acetylcholine agonist | 0.118 0.038 DBMET01843 | ||
| 0.272 | 0.148 | 0.272 | 15-Lipoxygenase inhibitor | 0.229 0.183 DBMET01842 | ||
| 0.131 | 0.01 | 0.131 | 5 Hydroxytryptamine 5 antagonist | 0.119 0.012 DBMET01843 0.056 0.042 DBMET01844 | ||
| 0.237 | 0.119 | 0.237 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.214 0.142 DBMET01843 | ||
| 0.136 | 0.028 | 0.136 | Acetylcholine release stimulant | 0.119 0.051 DBMET01842 0.107 0.072 DBMET01844 | ||
| 0.174 | 0.066 | 0.174 | ATPase inhibitor | 0.148 0.104 DBMET01842 | ||
| 0.131 | 0.023 | 0.131 | 5 Hydroxytryptamine 1A antagonist | 0.089 0.036 DBMET01842 0.088 0.037 DBMET01843 | ||
| 0.126 | 0.02 | 0.126 | Dopamine D4 antagonist | |||
| 0.204 | 0.103 | 0.212 | Aldehyde oxidase inhibitor | 0.212 0.098 DBMET01842 0.167 0.125 DBMET01843 | DBMET01842 | |
| 0.184 | 0.09 | 0.184 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.167 0.11 DBMET01843 | ||
| 0.108 | 0.015 | 0.108 | Alpha 1 adrenoreceptor agonist | 0.091 0.019 DBMET01842 0.058 0.039 DBMET01843 0.069 0.028 DBMET01844 | ||
| 0.119 | 0.027 | 0.134 | Acetylcholine nicotinic agonist | 0.134 0.022 DBMET01843 | DBMET01843 | |
| 0.107 | 0.015 | 0.107 | Sigma receptor antagonist | 0.089 0.018 DBMET01842 0.059 0.028 DBMET01843 0.065 0.025 DBMET01844 | ||
| 0.121 | 0.029 | 0.121 | Histamine N-methyltransferase inhibitor | 0.085 0.061 DBMET01842 0.105 0.041 DBMET01843 | ||
| 0.13 | 0.044 | 0.13 | Transcription factor STAT6 inhibitor | 0.116 0.067 DBMET01843 | ||
| 0.115 | 0.038 | 0.115 | Calcium antagonist | |||
| 0.091 | 0.014 | 0.091 | Histamine H3 receptor antagonist | 0.075 0.018 DBMET01843 | ||
| 0.095 | 0.019 | 0.095 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.212 | 0.139 | 0.311 | Insulysin inhibitor | 0.311 0.052 DBMET01843 | DBMET01843 | |
| 0.093 | 0.02 | 0.093 | Acetylcholine M3 receptor antagonist | 0.066 0.034 DBMET01843 | ||
| 0.09 | 0.022 | 0.106 | Adrenaline uptake inhibitor | 0.087 0.023 DBMET01842 0.106 0.017 DBMET01843 0.058 0.047 DBMET01844 | DBMET01843 | |
| 0.143 | 0.077 | 0.166 | Neuropeptide Y1 antagonist | 0.166 0.044 DBMET01843 | DBMET01843 | |
| 0.082 | 0.016 | 0.1 | Dopamine transporter inhibitor | 0.1 0.012 DBMET01842 0.07 0.02 DBMET01843 0.055 0.028 DBMET01844 | DBMET01842 | |
| 0.186 | 0.122 | 0.373 | Tumour necrosis factor alpha release inhibitor | 0.373 0.032 DBMET01842 0.312 0.049 DBMET01844 | DBMET01842 | |
| 0.27 | 0.212 | 0.27 | MAP kinase 1 inhibitor | |||
| 0.088 | 0.033 | 0.169 | Alpha adrenoreceptor agonist | 0.169 0.013 DBMET01843 | DBMET01843 | |
| 0.086 | 0.031 | 0.086 | Neuronal nicotinic receptor antagonist | 0.076 0.04 DBMET01843 | ||
| 0.069 | 0.018 | 0.091 | 5 Hydroxytryptamine 4 antagonist | 0.091 0.009 DBMET01842 0.057 0.027 DBMET01843 | DBMET01842 | |
| 0.222 | 0.172 | 0.426 | Beta lactamase inhibitor | 0.426 0.092 DBMET01844 | DBMET01844 | |
| 0.156 | 0.106 | 0.166 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.166 0.098 DBMET01843 | DBMET01843 | |
| 0.067 | 0.018 | 0.067 | Nicotinic receptor alpha4 subunit antagonist | 0.053 0.029 DBMET01842 0.053 0.028 DBMET01844 | ||
| 0.073 | 0.025 | 0.073 | Nicotinic neuronal receptor agonist | 0.062 0.034 DBMET01843 | ||
| 0.049 | 0.005 | 0.049 | 5 Hydroxytryptamine 6 agonist | 0.028 0.022 DBMET01842 0.049 0.005 DBMET01843 0.035 0.01 DBMET01844 | ||
| 0.071 | 0.027 | 0.071 | Acetylcholine muscarinic agonist | |||
| 0.069 | 0.025 | 0.111 | CC chemokine 2 receptor antagonist | 0.073 0.023 DBMET01842 0.111 0.011 DBMET01843 0.05 0.046 DBMET01844 | DBMET01843 | |
| 0.225 | 0.182 | 0.345 | Antiobesity | 0.345 0.09 DBMET01842 0.23 0.176 DBMET01843 | DBMET01842 | |
| 0.051 | 0.011 | 0.051 | Acetylcholine M4 receptor agonist | |||
| 0.054 | 0.014 | 0.054 | Nicotinic receptor beta4 subunit antagonist | 0.043 0.02 DBMET01842 0.043 0.02 DBMET01844 | ||
| 0.049 | 0.01 | 0.075 | Endothelial nitric-oxide synthase inhibitor | 0.075 0.005 DBMET01843 | DBMET01843 | |
| 0.131 | 0.094 | 0.131 | Cholinergic | |||
| 0.202 | 0.166 | 0.202 | Caspase 3 stimulant | |||
| 0.058 | 0.023 | 0.058 | Acetylcholine M1 receptor agonist | |||
| 0.129 | 0.096 | 0.129 | Diuretic | 0.121 0.103 DBMET01843 | ||
| 0.06 | 0.029 | 0.06 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.043 | 0.012 | 0.148 | Melanocortin 5 antagonist | 0.029 0.016 DBMET01842 0.148 0.005 DBMET01843 0.026 0.018 DBMET01844 | DBMET01843 | |
| 0.065 | 0.035 | 0.065 | Prolactin release inhibitor | 0.06 0.051 DBMET01844 | ||
| 0.083 | 0.054 | 0.083 | Caspase 7 inhibitor | |||
| 0.042 | 0.014 | 0.063 | ATM kinase inhibitor | 0.063 0.005 DBMET01842 | DBMET01842 | |
| 0.053 | 0.029 | 0.056 | Alpha 1b adrenoreceptor agonist | 0.056 0.024 DBMET01843 0.05 0.035 DBMET01844 | DBMET01843 | |
| 0.163 | 0.139 | 0.323 | Vasodilator | 0.323 0.041 DBMET01842 0.181 0.121 DBMET01843 | DBMET01842 | |
| 0.132 | 0.11 | 0.132 | Ca2+-transporting ATPase inhibitor | |||
| 0.056 | 0.035 | 0.056 | Nicotinic alpha7 receptor agonist | |||
| 0.11 | 0.091 | 0.189 | Cyclooxygenase 2 inhibitor | 0.189 0.034 DBMET01842 0.107 0.096 DBMET01843 | DBMET01842 | |
| 0.07 | 0.052 | 0.109 | Telomerase inhibitor | 0.109 0.03 DBMET01844 | DBMET01844 | |
| 0.118 | 0.102 | 0.118 | Cytidine deaminase inhibitor | |||
| 0.032 | 0.017 | 0.033 | Potassium channel (Inward rectifier) 1 blocker | 0.03 0.02 DBMET01842 0.033 0.014 DBMET01844 | DBMET01844 | |
| 0.046 | 0.032 | 0.046 | Adenylate cyclase 1 inhibitor | 0.046 0.031 DBMET01843 | ||
| 0.11 | 0.097 | 0.146 | Antibacterial (Helicobacter pylori) | 0.146 0.05 DBMET01842 | DBMET01842 | |
| 0.132 | 0.12 | 0.2 | Antipruritic | 0.2 0.049 DBMET01844 | DBMET01844 | |
| 0.045 | 0.035 | 0.064 | Melanocortin antagonist | 0.043 0.038 DBMET01842 0.064 0.018 DBMET01843 | DBMET01843 | |
| 0.154 | 0.145 | 0.216 | Cyclic AMP phosphodiesterase inhibitor | 0.216 0.083 DBMET01842 | DBMET01842 | |
| 0.115 | 0.106 | 0.204 | Cyclooxygenase inhibitor | 0.204 0.04 DBMET01842 0.115 0.105 DBMET01843 | DBMET01842 | |
| 0.062 | 0.053 | 0.062 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.07 | 0.062 | 0.07 | Analgesic, opioid | |||
| 0.054 | 0.047 | 0.054 | Prostaglandin EP2 antagonist | |||
| 0.074 | 0.067 | 0.074 | Acetylcholine M3 receptor agonist | |||
| 0.075 | 0.068 | 0.132 | Neuropeptide Y antagonist | 0.132 0.026 DBMET01843 | DBMET01843 | |
| 0.113 | 0.108 | 0.113 | Neurotrophic factor | |||
| 0.082 | 0.078 | 0.082 | Polo-like kinase-1 inhibitor | |||
| 0.068 | 0.064 | 0.068 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.026 | 0.022 | 0.026 | Myristoyl transferase inhibitor | |||
| 0.044 | 0.041 | 0.044 | 5 Hydroxytryptamine 1 agonist | |||
| 0.058 | 0.057 | 0.09 | 5 Hydroxytryptamine agonist | 0.09 0.037 DBMET01843 | DBMET01843 | |
| 0.016 | 0.016 | 0.017 | Complement factor 1 inhibitor | 0.017 0.014 DBMET01843 | DBMET01843 | |
| 0.091 | 0.094 | 0.15 | Protein kinase C gamma inhibitor | 0.15 0.032 DBMET01842 | DBMET01842 | |
| 0.033 | 0.038 | 0.039 | Glucose-6-phosphate dehydrogenase inhibitor | 0.039 0.024 DBMET01843 | DBMET01843 | |
| 0.173 | 0.179 | 0.233 | Prostaglandin dehydrogenase inhibitor | 0.233 0.136 DBMET01842 | DBMET01842 | |
| 0.085 | 0.101 | 0.102 | Adenylate cyclase inhibitor | 0.102 0.083 DBMET01843 | DBMET01843 | |
| 0.155 | 0.172 | 0.183 | Calpain inhibitor | 0.183 0.131 DBMET01843 | DBMET01843 | |
| 0.131 | 0.148 | 0.138 | P-glycoprotein inhibitor | 0.138 0.136 DBMET01844 | DBMET01844 | |
| 0.038 | 0.058 | 0.064 | 5 Hydroxytryptamine 2 agonist | 0.064 0.023 DBMET01843 | DBMET01843 | |
| 0.038 | 0.059 | 0.046 | Neuropeptide Y5 antagonist | 0.046 0.041 DBMET01843 | DBMET01843 | |
| 0.02 | 0.043 | 0.027 | Peptide deformylase inhibitor | 0.027 0.025 DBMET01842 | DBMET01842 | |
| 0.049 | 0.074 | 0.06 | Gonadotropin-releasing hormone receptor agonist | 0.06 0.04 DBMET01843 | DBMET01843 | |
| 0.027 | 0.053 | 0.165 | Neurokinin 2 antagonist | 0.165 0.005 DBMET01842 0.04 0.03 DBMET01844 | DBMET01842 | |
| 0.054 | 0.08 | 0.077 | Protein kinase C beta inhibitor | 0.077 0.035 DBMET01842 | DBMET01842 | |
| 0.013 | 0.04 | 0.019 | Imidazoline I1 receptor antagonist | 0.019 0.017 DBMET01843 | DBMET01843 | |
| 0.084 | 0.112 | 0.114 | Multidrug resistance-associated protein 1 inhibitor | 0.114 0.056 DBMET01842 | DBMET01842 | |
| 0.015 | 0.045 | 0.057 | Growth hormone secretagogue receptor agonist | 0.057 0.017 DBMET01843 | DBMET01843 | |
| 0.035 | 0.066 | 0.052 | Potassium channel (Inward rectifier) blocker | 0.052 0.032 DBMET01842 0.051 0.033 DBMET01844 | DBMET01842 | |
| 0.107 | 0.142 | 0.145 | MAP3K9 inhibitor | 0.145 0.068 DBMET01843 | DBMET01843 | |
| 0.028 | 0.075 | 0.086 | Phenylethanolamine N methyltransferase inhibitor | 0.086 0.004 DBMET01843 | DBMET01843 | |
| 0.076 | 0.125 | 0.325 | MAP kinase 13 inhibitor | 0.325 0.005 DBMET01842 0.105 0.074 DBMET01843 | DBMET01842 | |
| 0.08 | 0.144 | 0.133 | Cytokine production inhibitor | 0.133 0.077 DBMET01842 | DBMET01842 | |
| 0.165 | 0.228 | 0.191 | Antithrombotic | 0.191 0.189 DBMET01842 | DBMET01842 | |
| 0.145 | 0.209 | 0.274 | Peptidyltransferase inhibitor | 0.274 0.036 DBMET01842 0.171 0.145 DBMET01844 | DBMET01842 | |
| 0.021 | 0.085 | 0.067 | NMDA 2A receptor antagonist | 0.067 0.026 DBMET01843 | DBMET01843 | |
| 0.025 | 0.089 | 0.115 | Beta tubulin antagonist | 0.115 0.019 DBMET01844 | DBMET01844 | |
| 0.157 | 0.224 | 0.209 | Nootropic | 0.209 0.147 DBMET01842 | DBMET01842 | |
| 0.035 | 0.104 | 0.087 | Alpha 2 adrenoreceptor agonist | 0.087 0.019 DBMET01843 | DBMET01843 | |
| 0.138 | 0.208 | 0.318 | MAP-kinase-activated kinase 5 inhibitor | 0.318 0.021 DBMET01842 | DBMET01842 | |
| 0.037 | 0.108 | 0.058 | Glucosylceramidase inhibitor | 0.058 0.034 DBMET01843 | DBMET01843 | |
| 0.08 | 0.164 | 0.12 | Interleukin 8 antagonist | 0.12 0.061 DBMET01842 0.102 0.092 DBMET01843 | DBMET01842 | |
| 0.023 | 0.119 | 0.048 | Protein 50S ribosomal subunit inhibitor | 0.048 0.042 DBMET01842 | DBMET01842 | |
| 0.063 | 0.161 | 0.312 | MAP kinase 12 inhibitor | 0.312 0.005 DBMET01842 0.101 0.097 DBMET01843 | DBMET01842 | |
| 0.011 | 0.11 | 0.054 | 5 Hydroxytryptamine 2C agonist | 0.054 0.025 DBMET01843 | DBMET01843 | |
| 0.011 | 0.111 | 0.06 | Gonadotropin-releasing hormone receptor antagonist | 0.06 0.014 DBMET01843 | DBMET01843 | |
| 0.061 | 0.169 | 0.111 | Tubulin antagonist | 0.111 0.089 DBMET01844 | DBMET01844 | |
| 0.021 | 0.13 | 0.108 | Neurokinin antagonist | 0.108 0.009 DBMET01842 | DBMET01842 | |
| 0.027 | 0.144 | 0.23 | MAP kinase 11 inhibitor | 0.23 0.007 DBMET01842 | DBMET01842 | |
| 0.058 | 0.18 | 0.147 | Histone deacetylase class III inhibitor | 0.147 0.046 DBMET01842 | DBMET01842 | |
| 0.122 | 0.245 | 0.399 | 5 Hydroxytryptamine release stimulant | 0.399 0.046 DBMET01842 | DBMET01842 | |
| 0.043 | 0.179 | 0.08 | Inducible nitric-oxide synthase inhibitor | 0.08 0.062 DBMET01843 | DBMET01843 | |
| 0.016 | 0.156 | 0.032 | Benzodiazepine receptor peripheral-type antagonist | 0.032 0.029 DBMET01844 | DBMET01844 | |
| 0.024 | 0.17 | 0.058 | Myc inhibitor | 0.058 0.033 DBMET01842 0.056 0.036 DBMET01843 | DBMET01842 | |
| 0.037 | 0.193 | 0.086 | Adrenaline agonist | 0.086 0.05 DBMET01843 | DBMET01843 | |
| 0.028 | 0.188 | 0.103 | Histone deacetylase SIRT2 inhibitor | 0.103 0.027 DBMET01842 | DBMET01842 | |
| 0.082 | 0.247 | 0.135 | Adenylate cyclase stimulant | 0.135 0.092 DBMET01843 | DBMET01843 | |
| 0.009 | 0.185 | 0.076 | Neurokinin 3 antagonist | 0.076 0.01 DBMET01842 | DBMET01842 | |
| 0.006 | 0.204 | 0.029 | Sirtuin 2 inhibitor | 0.029 0.027 DBMET01842 | DBMET01842 | |
| 0.11 | 0.325 | 0.198 | Vasodilator, peripheral | 0.198 0.178 DBMET01842 | DBMET01842 | |
| 0.104 | 0.417 | 0.256 | Calcium channel activator | 0.256 0.14 DBMET01842 | DBMET01842 | |
| 0.041 | 0.374 | 0.523 | Interleukin 1 antagonist | 0.523 0.005 DBMET01842 0.184 0.04 DBMET01844 | DBMET01842 | |
| 0.013 | 0.382 | 0.06 | Leukotriene synthesis inhibitor | 0.06 0.055 DBMET01844 | DBMET01844 | |
| 0.042 | 0.463 | 0.416 | Interleukin 6 antagonist | 0.416 0.007 DBMET01842 | DBMET01842 | |
| 0.003 | 0.437 | 0.02 | Somatostatin 2 agonist | 0.02 0.006 DBMET01843 | DBMET01843 | |
| 0.018 | 0.546 | 0.082 | Viral attachment inhibitor | 0.082 0.046 DBMET01842 | DBMET01842 | |
| 0.018 | 0.627 | 0.373 | Interleukin antagonist | 0.373 0.035 DBMET01842 | DBMET01842 | |
| 0.019 | 0.745 | 0.264 | Interleukin 1b antagonist | 0.264 0.011 DBMET01842 0.127 0.057 DBMET01844 | DBMET01842 | |
| 0.015 | 0.763 | 0.317 | EphB2 antagonist | 0.317 0.031 DBMET01842 | DBMET01842 | |
| 0.005 | 0.795 | 0.06 | H+/K+-transporting ATPase inhibitor | 0.06 0.025 DBMET01842 | DBMET01842 | |
| 0.028 | 0.872 | 0.301 | Death-associated protein kinase 2 inhibitor | 0.301 0.007 DBMET01842 | DBMET01842 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |